Skip to main content
Livermore
Livermore
ZHEN

Bender Robert & Associates

SEC CIK
0000894300
Latest filing
Jul 30, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Bender Robert & Associates, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
26,303
Value
$13.1M
% of portfolio
2.7%
Quarters held
21
Since Q1 2021
Holdings of VRTX by Bender Robert & Associates, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202626,303$13.1M2.7%+132+0.5%AddedHolders
Q1 202626,171$11.7M2.8%−292−1.1%ReducedHolders
Q4 202526,463$12.0M2.5%+133+0.5%AddedHolders
Q3 202526,330$10.3M2.2%−382−1.4%ReducedHolders
Q2 202526,712$11.9M2.7%−313−1.2%ReducedHolders
Q1 202527,025$13.1M3.3%−281−1.0%ReducedHolders
Q4 202427,306$11.0M2.7%+172+0.6%AddedHolders
Q3 202427,134$12.6M2.7%+27,134NewHolders
Q2 20240$00.0%−28,172−100.0%Sold outHolders
Q1 202428,172$11.8M2.8%−378−1.3%ReducedHolders
Q4 202328,550$11.6M2.9%+96+0.3%AddedHolders
Q3 202328,454$9.89M2.9%+47+0.2%AddedHolders
Q2 202328,407$10.0M2.8%−430−1.5%ReducedHolders
Q1 202328,837$9.09M2.8%−22−0.1%ReducedHolders
Q4 202228,859$8.33M3.1%+50.0%AddedHolders
Q3 202228,854$8.35M3.2%+683+2.4%AddedHolders
Q2 202228,171$7.94M3.0%−271−1.0%ReducedHolders
Q1 202228,442$7.42M2.1%−1,668−5.5%ReducedHolders
Q4 202130,110$5.46M1.6%00.0%UnchangedHolders
Q3 202130,110$5.46M1.6%−273−0.9%ReducedHolders
Q2 202130,383$6.13M1.7%+238+0.8%AddedHolders
Q1 202130,145$6.48M2.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.